"He's 10 and Weighs 70kg"... Debate Grows in U.S. as Parents Turn to Obesity Injections
10-Year-Old Barred from Football League Begins Wegovy Treatment
Parents Note Changes: “Thinking Less About Food”
“Necessary for Severe Obesity” vs. “Still Lacking Research”
Controversy is rising in the United States as more parents are giving obesity treatment drugs to children who are under the approved age threshold.
Photo to aid understanding of the article showing Wegovy, a GLP-1 class obesity treatment drug. Photo by Reuters Yonhap News.
View original imageOn August 17 (local time), the New York Post reported cases showing that an increasing number of parents in the U.S. are seeking to use glucagon-like peptide-1 (GLP-1) class drugs such as Wegovy on their children who suffer from health problems due to obesity.
Jenna Seriani, who lives near Boston, Massachusetts, began GLP-1 therapy for her 10-year-old son after his weight increased to about 70 kilograms. Her son was removed from the youth American football league after surpassing the league's weight limit of roughly 57 kilograms. Seriani shared, “We chose medication for his health,” adding, “This isn’t only about weight — we want him to grow up healthy and avoid conditions like diabetes in the long run.” Her 14-year-old daughter, who had been struggling with obsessive thoughts about food and metabolic issues, also started GLP-1 treatment.
Angela, who resides in Pennsylvania, also began administering Wegovy to her teenage daughter. Despite regular exercise, her daughter struggled with persistent, obsessive thoughts about food. With a height of about 160 centimeters and a weight of 77.6 kilograms, her daughter had experienced significant weight gain since the age of nine. She had not started menstruating even as she entered puberty, raising concerns about the possibility of polycystic ovary syndrome and metabolic abnormalities. Although they received nutritional counseling and saw an endocrinology specialist, her daughter’s preoccupation with food continued. Angela said, “Six weeks after starting Wegovy, she began to think much less about food.”
Seriani also noted that after about two months of using Wegovy, her son started to distinguish between eating out of boredom and real hunger. She remarked that when he once said he was "full," she was very surprised to hear it.
The core of the controversy is age. Among GLP-1 drugs approved by the U.S. Food and Drug Administration (FDA) as obesity treatments for adolescents, only Saxenda and Wegovy are authorized for those aged 12 and older. Guidelines by the American Academy of Pediatrics also recommend drug therapy starting from age 12. Using such drugs for those younger than 12, as in Seriani’s son’s case, constitutes off-label use. The key issue is whether it is appropriate to intervene in childhood obesity with medication from such a young age.
Some experts argue that medication may be necessary in cases of severe pediatric obesity. Dr. Shaista Safder said, “I have seen young patients develop fatty liver and subsequent liver dysfunction,” stressing, “We have to intervene before irreversible damage occurs.” Dr. Anna Trepeckli of a pediatric obesity clinic that offers GLP-1 therapy noted, “Obesity cannot be viewed solely as a lifestyle problem,” explaining that “Obesity is a chronic disease, and medication can give children time to practice nutritional management, exercise, and behavioral correction.”
On the other hand, concerns are being raised about the lack of sufficient research into possible side effects of long-term drug use in growing children and into the impact on puberty and development. There is also criticism that early medication could fuel a body image-centered diet culture.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Meanwhile, data from the U.S. Centers for Disease Control and Prevention (CDC) indicates that about 22% of those aged 12 to 19 in the United States are obese. Among the world’s population aged 5 to 19, the proportion who are overweight or obese surged from about 8% in 1990 to approximately 20% in 2022.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.